Changes in LDL-cholesterol levels following aromatase inhibitor treatment in early postmenopausal breast cancer. [PDF]
Lund M +8 more
europepmc +1 more source
24-week home-based walking program in the early adjuvant setting in breast cancer patients who receive aromatase inhibitor endocrine therapy: lessons learned from the SAKK 95/17 WISE prospective, randomized, multicenter trial. [PDF]
Güth U +17 more
europepmc +1 more source
OATP1B-type Transport Function Is a Determinant of Aromatase Inhibitor-Associated Arthralgia Susceptibility. [PDF]
Taheri H +16 more
europepmc +1 more source
The role of exercise in aromatase inhibitor-induced arthralgia. [PDF]
Yu K +7 more
europepmc +1 more source
Aromatase Inhibitor Monotherapy to Augment Height in Boys: Does It Work and Is It Safe? [PDF]
Geffner ME.
europepmc +1 more source
Matching-adjusted indirect comparison of ribociclib + nonsteroidal aromatase inhibitor versus abemaciclib + endocrine therapy in hormone receptor-positive/HER2-negative early breast cancer. [PDF]
Chia S +8 more
europepmc +1 more source
Real-world clinical outcomes associated with first-line palbociclib and aromatase inhibitor therapy among patients with HR+/HER2- advanced breast cancer in Europe. [PDF]
Oikonomidou O +13 more
europepmc +1 more source
Role function in postmenopausal women during aromatase inhibitor therapy for breast cancer. [PDF]
Melnyk H +5 more
europepmc +1 more source

